Mesoblast Stock Analysis

MEOBF Stock  USD 0.61  0.01  1.67%   
Mesoblast is overvalued with Real Value of 0.5 and Hype Value of 0.61. The main objective of Mesoblast pink sheet analysis is to determine its intrinsic value, which is an estimate of what Mesoblast is worth, separate from its market price. There are two main types of Mesoblast's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Mesoblast's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Mesoblast's stock to identify patterns and trends that may indicate its future price movements.
The Mesoblast pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Mesoblast is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Mesoblast Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mesoblast's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Mesoblast Pink Sheet please use our How to Invest in Mesoblast guide.

Mesoblast Pink Sheet Analysis Notes

About 26.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mesoblast recorded a loss per share of 0.14. The entity had not issued any dividends in recent years. The firm had 1:1 split on the 29th of August 2017. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia. Mesoblast operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 77 people.The quote for Mesoblast is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Mesoblast contact FACP FACRA at 61 3 9639 6036 or learn more at https://www.mesoblast.com.

Mesoblast Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mesoblast's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mesoblast or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mesoblast is way too risky over 90 days horizon
Mesoblast has some characteristics of a very speculative penny stock
Mesoblast appears to be risky and price may revert if volatility continues
The company reported the revenue of 10.21 M. Net Loss for the year was (91.35 M) with loss before overhead, payroll, taxes, and interest of (53.36 M).
Mesoblast has accumulated about 60.45 M in cash with (65.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.

Mesoblast Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 544.31 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mesoblast's market, we take the total number of its shares issued and multiply it by Mesoblast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 24th of April, Mesoblast secures the Standard Deviation of 16.25, mean deviation of 5.14, and Risk Adjusted Performance of 0.1125. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mesoblast, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed twelve technical drivers for Mesoblast, which can be compared to its peers in the industry. Please verify Mesoblast coefficient of variation, as well as the relationship between the total risk alpha and potential upside to decide if Mesoblast is priced some-what accurately, providing market reflects its recent price of 0.61 per share. As Mesoblast is a penny stock we also strongly advise to check its jensen alpha numbers.

Mesoblast Price Movement Analysis

The output start index for this execution was seven with a total number of output elements of fifty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mesoblast middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mesoblast. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mesoblast Predictive Daily Indicators

Mesoblast intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mesoblast pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mesoblast Forecast Models

Mesoblast's time-series forecasting models are one of many Mesoblast's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mesoblast's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mesoblast Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Mesoblast prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mesoblast shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Mesoblast. By using and applying Mesoblast Pink Sheet analysis, traders can create a robust methodology for identifying Mesoblast entry and exit points for their positions.
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia. Mesoblast operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 77 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Mesoblast to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Mesoblast Pink Sheet please use our How to Invest in Mesoblast guide.
Note that the Mesoblast information on this page should be used as a complementary analysis to other Mesoblast's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Mesoblast Pink Sheet analysis

When running Mesoblast's price analysis, check to measure Mesoblast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesoblast is operating at the current time. Most of Mesoblast's value examination focuses on studying past and present price action to predict the probability of Mesoblast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesoblast's price. Additionally, you may evaluate how the addition of Mesoblast to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.